Skip to main content

Table 3 Prevalence of anaemia (< 10 g/dL) at month 12 following ARV initiation

From: Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America

 

Initial ARV combination containing AZT

Initial ARV combination containing d4T

 

Anaemic at month 12 following ARV initiation

Baseline haemoglobin (g/dL)

No

Yes

No

Yes

13+

988 (93%)

79 (7%)

2607 (98%)

56 (2%)

12~ < 13

664 (87%)

95 (13%)

1881 (97%)

60 (3%)

11~ < 12

734 (79%)

197 (21%)

2218 (92%)

198 (8%)

10~ < 11

642 (69%)

286 (31%)

2137 (85%)

382 (15%)

< 10

487 (42%)

672 (58%)

3438 (66%)

1743 (34%)